President Trump gave Republicans a powerful, tangible achievement when he launched TrumpRx.gov. For the first time in years, we are doing something about lowering prescription drug prices.
TrumpRx delivers steep discounts on brand-name medications that families across Tennessee rely on every day. From weight-loss drugs to diabetes treatments, fertility medications to inhalers, prices that often feel impossible are now within reach. For voters squeezed by inflation and healthcare costs, this is exactly the kind of policy that Republicans should be rallying behind heading into November.
But here in Tennessee, we are on the verge of sabotaging it.
The so-called “FAIR Rx Act” (SB 2040/HB 1959) would prohibit pharmacy benefit managers from owning or operating pharmacies in the state. Supporters frame it as reform. In practice, it would gut the very chain pharmacies that make TrumpRx possible.
TrumpRx does not ship medication directly to patients. It provides discount cards that must be presented at participating retail pharmacies. That means the entire program depends on brick-and-mortar pharmacies being open, accessible, and operational.
National chains, including CVS, Walgreens, Kroger, Albertsons, and Costco, are the backbone of that distribution network. CVS alone operates more than 130 pharmacy locations in Tennessee and serves roughly 1.5 million patients annually. These stores do not represent a marginal slice of the market. They fill a significant share of prescriptions across the state, often at volumes far greater than independent pharmacies can handle.
If the FAIR Rx Act passes as written, it would force the closure of those CVS locations and other affected chain operations. The result would not be a smooth transition.
Independent pharmacies provide important community care, but they are not positioned to absorb the sudden displacement of hundreds of thousands of patients. We have seen in other states what happens when large chains close: long wait times, prescription backlogs, and independent operators openly admitting they cannot take on the volume. This is exactly what happened in Pennsylvania last summer, when Rite Aid pharmacies closed and independent pharmacists admitted to struggling to absorb Rite Aid’s existing patients left in limbo.
Now consider the political reality.
If Tennessee eliminates a major portion of the pharmacy infrastructure that accepts TrumpRx discounts, what happens to the program here? It becomes largely theoretical. The discounts will still exist online, but if patients cannot easily find a participating pharmacy, the benefit becomes hollow.
In other words, FAIR Rx Act could effectively make TrumpRx useless within our borders.
And Republicans would own that outcome.
President Trump has made lowering drug prices a centerpiece of his healthcare message. He has called TrumpRx “one of the most transformative health care initiatives of all time.” As we approach the November elections, Republicans plan to campaign on cost-of-living relief and healthcare affordability.
How do we defend that message if red states undermine the President’s marquee initiative?
Democrats are already preparing their own drug pricing proposals. If the FAIR Rx Act results in pharmacy closures and access problems, they will not hesitate to argue that Republicans cannot even manage their own reforms. Worse, voters who were promised lower prices will simply see disruption and confusion.
As a Republican consultant in this state, I can tell you that suburban families, seniors, and working-class voters care far more about access and affordability than they do about industry structure debates. If their pharmacy closes and their prescription becomes harder to fill, they will not parse the nuances. They will blame the party in power.
That is a risk we cannot afford.
If the goal is to protect patients, lawmakers should refine the policy, not detonate the distribution system that makes TrumpRx work. At a minimum, implementation should not come at the cost of eliminating major pharmacy access points before a workable alternative exists.
President Trump delivered a breakthrough on drug prices. Tennessee Republicans should be protecting it, strengthening it, and showcasing it.
Passing legislation that guts the pharmacies required to make it function is not reform. It is political self-sabotage, and it could cost us far more than we realize this November.
Austin Marquette is the Founder of Clear Path Strategies and a Republican strategist.
